MarketBeat Instant News Alerts 2 hours agoAmphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Target Raised at Wells Fargo & CompanyMarketBeatWells Fargo & Company increased their price objective on Amphastar Pharmaceuticals from $20.00 to $25.00 and gave the stock an "equal weight" rating in a report on Friday.NASDAQ:AMPHRead Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Target Raised at Wells Fargo & Company2 hours agoSolventum (NYSE:SOLV) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysMarketBeatWells Fargo & Company raised their price target on Solventum from $89.00 to $95.00 and gave the company an "equal weight" rating in a report on Friday.NYSE:SOLVRead Solventum (NYSE:SOLV) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says2 hours agoiRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $135.00 by Analysts at Wells Fargo & CompanyMarketBeatWells Fargo & Company decreased their price target on shares of iRhythm Technologies from $150.00 to $135.00 and set an "overweight" rating on the stock in a research report on Friday.NASDAQ:IRTCRead iRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $135.00 by Analysts at Wells Fargo & Company2 hours agoBeOne Medicines (NASDAQ:ONC) Given New $435.00 Price Target at Wells Fargo & CompanyMarketBeatWells Fargo & Company upped their target price on BeOne Medicines from $400.00 to $435.00 and gave the company an "overweight" rating in a research report on Friday.NASDAQ:ONCRead BeOne Medicines (NASDAQ:ONC) Given New $435.00 Price Target at Wells Fargo & Company2 hours agoFate Therapeutics (NASDAQ:FATE) Given New $3.00 Price Target at Wells Fargo & CompanyMarketBeatWells Fargo & Company lowered their price objective on Fate Therapeutics from $3.50 to $3.00 and set an "equal weight" rating on the stock in a research note on Friday.NASDAQ:FATERead Fate Therapeutics (NASDAQ:FATE) Given New $3.00 Price Target at Wells Fargo & Company2 hours agoVerisk Analytics (NASDAQ:VRSK) Stock Price Target Raised at Wells Fargo & CompanyMarketBeatWells Fargo & Company upped their price target on shares of Verisk Analytics from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Friday.NASDAQ:VRSKRead Verisk Analytics (NASDAQ:VRSK) Stock Price Target Raised at Wells Fargo & Company Trending News1Fermi Advances Project Matador, Pivots to Powered-Land Strategy as Director Vote Fails220,118 AST SpaceMobile, Inc. $ASTS Shares Acquired by International Assets Investment Management LLC3Compass Pathways (NASDAQ:CMPS) Stock Falls 7.1% - Should You Sell?4Apple Q4 Earnings Call Highlights5NVIDIA (NASDAQ:NVDA) Stock Falls 3.2% - Time to Sell?6110,309 Shares of MNTN Inc. $MNTN Bought by One Way Holdings LLC7Sable Offshore (SOC) Projected to Post Earnings on Monday8What Palantir Technologies (PLTR) Said on Its Q3 Earnings Call All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoHorizon Technology Finance Corporation (NASDAQ:HRZN) Shareholders to Get $0.06 Monthly DividendMarketBeatNASDAQ:HRZNRead Horizon Technology Finance Corporation (NASDAQ:HRZN) Shareholders to Get $0.06 Monthly Dividend2 hours ago3D Systems (NYSE:DDD) Stock Rating Cut to "Hold" at Craig HallumMarketBeatNYSE:DDDRead 3D Systems (NYSE:DDD) Stock Rating Cut to "Hold" at Craig Hallum2 hours agoEnerflex (NYSE:EFXT) Reaches New 1-Year Low - Time to Sell?MarketBeatNYSE:EFXTRead Enerflex (NYSE:EFXT) Reaches New 1-Year Low - Time to Sell?2 hours agoChatham Lodging Trust (REIT) (NYSE:CLDT) Plans Quarterly Dividend of $0.10MarketBeatNYSE:CLDTRead Chatham Lodging Trust (REIT) (NYSE:CLDT) Plans Quarterly Dividend of $0.102 hours agoHA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) Shares Set to Pay Quarterly Dividend of $0.42MarketBeatNYSE:HASIRead HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) Shares Set to Pay Quarterly Dividend of $0.422 hours agoXeris Biopharma (NASDAQ:XERS) Earns "Neutral" Rating from Piper SandlerMarketBeatNASDAQ:XERSRead Xeris Biopharma (NASDAQ:XERS) Earns "Neutral" Rating from Piper Sandler2 hours agoWells Fargo & Company Has Lowered Expectations for Tandem Diabetes Care (NASDAQ:TNDM) Stock PriceMarketBeatNASDAQ:TNDMRead Wells Fargo & Company Has Lowered Expectations for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price2 hours agoProspect Capital (NASDAQ:PSEC) Stock Price Target Cut by Wells Fargo & CompanyMarketBeatNASDAQ:PSECRead Prospect Capital (NASDAQ:PSEC) Stock Price Target Cut by Wells Fargo & Company2 hours agoPrivia Health Group (NASDAQ:PRVA) Stock Price Target Raised at Piper SandlerMarketBeatNASDAQ:PRVARead Privia Health Group (NASDAQ:PRVA) Stock Price Target Raised at Piper Sandler2 hours agoWells Fargo & Company Has Lowered Expectations for Omada Health (NASDAQ:OMDA) Stock PriceMarketBeatNASDAQ:OMDARead Wells Fargo & Company Has Lowered Expectations for Omada Health (NASDAQ:OMDA) Stock Price2 hours agoMicrochip Technology (NASDAQ:MCHP) Given New $120.00 Price Target at KeyCorpMarketBeatNASDAQ:MCHPRead Microchip Technology (NASDAQ:MCHP) Given New $120.00 Price Target at KeyCorp2 hours agoLifeStance Health Group (NASDAQ:LFST) Given New $17.00 Price Target at KeyCorpMarketBeatNASDAQ:LFSTRead LifeStance Health Group (NASDAQ:LFST) Given New $17.00 Price Target at KeyCorp2 hours agoKeyCorp Issues Positive Forecast for ICU Medical (NASDAQ:ICUI) Stock PriceMarketBeatNASDAQ:ICUIRead KeyCorp Issues Positive Forecast for ICU Medical (NASDAQ:ICUI) Stock Price2 hours agoHalozyme Therapeutics (NASDAQ:HALO) Stock Price Target Raised at Wells Fargo & CompanyMarketBeatNASDAQ:HALORead Halozyme Therapeutics (NASDAQ:HALO) Stock Price Target Raised at Wells Fargo & Company2 hours agoWells Fargo & Company Issues Pessimistic Forecast for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock PriceMarketBeatNASDAQ:GLUERead Wells Fargo & Company Issues Pessimistic Forecast for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Price2 hours agoJFrog (NASDAQ:FROG) Stock Gets Price Target Bump from Piper SandlerMarketBeatNASDAQ:FROGRead JFrog (NASDAQ:FROG) Stock Gets Price Target Bump from Piper Sandler2 hours agoKeyCorp Issues Positive Forecast for JFrog (NASDAQ:FROG) Stock PriceMarketBeatNASDAQ:FROGRead KeyCorp Issues Positive Forecast for JFrog (NASDAQ:FROG) Stock Price2 hours agoPiper Sandler Reaffirms Neutral Rating for Airbnb (NASDAQ:ABNB)MarketBeatNASDAQ:ABNBRead Piper Sandler Reaffirms Neutral Rating for Airbnb (NASDAQ:ABNB)2 hours agoKeyCorp Issues Positive Forecast for Vontier (NYSE:VNT) Stock PriceMarketBeatNYSE:VNTRead KeyCorp Issues Positive Forecast for Vontier (NYSE:VNT) Stock Price2 hours agoWells Fargo & Company Forecasts Strong Price Appreciation for Teleflex (NYSE:TFX) StockMarketBeatNYSE:TFXRead Wells Fargo & Company Forecasts Strong Price Appreciation for Teleflex (NYSE:TFX) Stock2 hours agoSTERIS (NYSE:STE) Price Target Raised to $284.00MarketBeatNYSE:STERead STERIS (NYSE:STE) Price Target Raised to $284.002 hours agoSolventum (NYSE:SOLV) Stock Keeps "Overweight" Rating at Piper SandlerMarketBeatNYSE:SOLVRead Solventum (NYSE:SOLV) Stock Keeps "Overweight" Rating at Piper Sandler2 hours agoKeyCorp Issues Positive Forecast for Sweetgreen (NYSE:SG) Stock PriceMarketBeatNYSE:SGRead KeyCorp Issues Positive Forecast for Sweetgreen (NYSE:SG) Stock Price2 hours agoPlanet Fitness (NYSE:PLNT) Stock Price Expected to Rise, KeyCorp Analyst SaysMarketBeatNYSE:PLNTRead Planet Fitness (NYSE:PLNT) Stock Price Expected to Rise, KeyCorp Analyst Says Featured Articles and OffersAbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestBy Thomas Hughes | November 2, 2026Financial legend: “This is bad, really bad...”From Weiss Ratings (Ad)Marriott's Earnings Beat Shows Why It's More Than a Bet on Travel DemandBy Chris Markoch | November 3, 2026Why JFrog Could Be the Software Infrastructure Company to Beat in the AI BoomBy Nathan Reiff | October 31, 2026Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price TagBy Leo Miller | November 1, 2026Don't lose access to thisFrom TradeWins (Ad)3 Waste Services Stocks With More Growth Than You Might ExpectBy Nathan Reiff | November 2, 2026Amazon's Record Margins Couldn't Stop the Sell-Off—Here's WhyBy Sam Quirke | October 30, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 483 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
